Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients
Open Access
- 1 July 2003
- Vol. 52 (7), 1035-1040
- https://doi.org/10.1136/gut.52.7.1035
Abstract
Objectives: To compare the rate of hepatic fibrosis progression in hepatitis C virus (HCV) infected and human immunodeficiency virus (HIV)-HCV coinfected patients, and to identify factors that may influence fibrosis progression. Patients and methods: A total of 153 HCV infected and 55 HCV-HIV coinfected patients were identified from two London hospitals. Eligible patients had known dates of HCV acquisition, were HCV-RNA positive, and had undergone a liver biopsy, which was graded using the Ishak score. Univariate and multivariate logistic regression analyses were used to identify factors associated with fibrosis progression rate and the development of advanced fibrosis (stages 3 and 4). Results: The estimated median fibrosis progression rate was 0.17 units/year (interquartile range (IQR) 0.10–0.25) in HIV-HCV coinfected and 0.13 (IQR 0.07–0.17) in HCV monoinfected patients (p=0.01), equating to an estimated time from HCV infection to cirrhosis of 23 and 32 years, respectively. Older age at infection (pr=0.35, p6/l was independently associated with advanced liver fibrosis (odds ratio 5.36 (95% confidence interval 1.26–22.79)) and was also correlated with a higher histological index (r=−0.42, p=0.002). Conclusion: HIV infection modifies the natural history of HCV by accelerating the rate of fibrosis progression by 1.4 fold, and the development of advanced fibrosis threefold. A low CD4 cell count was independently associated with advanced disease and correlated with higher histological index, which suggests that early antiretroviral therapy may be of benefit in slowing HCV progression in coinfected patients.Keywords
This publication has 46 references indexed in Scilit:
- Increasing Impact of Chronic Viral Hepatitis on Hospital Admissions and Mortality among HIV-Infected PatientsAIDS Research and Human Retroviruses, 2001
- Mortality among Human Immunodeficiency Virus-Infected Patients with Cirrhosis or Hepatocellular Carcinoma Due to Hepatitis C Virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997Clinical Infectious Diseases, 2001
- Clinical outcome of hepatitis C as a function of mode of transmissionHepatology, 1998
- Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosisJournal of Hepatology, 1997
- Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosisHepatology, 1997
- The natural history of chronic hepatitis C in haemophiliacsBritish Journal of Haematology, 1996
- The virological and histological states of anti-hepatitis C virus?positive subjects with normal liver biochemical valuesHepatology, 1995
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver diseaseJournal of Hepatology, 1994
- Hepatitis C virus genotypes are not responsible for development of serious liver diseaseDigestive Diseases and Sciences, 1994